de GreyADNJ. Competing causes of chronic ill health: What do we do and what should we do?. Rejuvenation Res, 2013; 16:1–2.
8.
de GreyADNJ. The desperate need for a biomedically useful definition of “aging.”. Rejuvenation Res, 2013; 16:89–90.
9.
de GreyADNJ. Late-onset, preventative, combination treatments: The triple challenge facing the most promising anti-aging research paradigm. Rejuvenation Res, 2013; 16:177–178.
10.
de GreyADNJ. A divide-and-conquer assault on aging: Mainstream at last. Rejuvenation Res, 2013; 16:257–258.
11.
de GreyADNJ. Google's Calico: The war on aging has truly begun. Rejuvenation Res, 2013; 16:343–343.
12.
de GreyADNJ. Selling anti-aging research: The perils of mixed messages. Rejuvenation Res, 2013; 16:443–445.
13.
de GreyAD. The rational imperative to aim high. Rejuvenation Res, 2014; 17:413–414.
14.
de GreyAD. The practicality or otherwise of biomedical rejuvenation therapies: A response to Kyriazis. Rejuvenation Res, 2014; 17:397–400.
15.
de GreyAD. Scientific debate is an opportunity, not a chore: It benefits the establishment, the heretic, and the observer alike. Rejuvenation Res, 2014; 17:323–324.
16.
de GreyAD. Predicting future longevity: At long last, extrapolation is on the way out. Rejuvenation Res, 2014; 17:247–248.
17.
de GreyAD. The real end of ageism. Rejuvenation Res, 2014; 17:95–96.
18.
ApplebyJ. The geroscience interest group (GSIG): Tracing pathological consequences of fundamental aging processes. Rejuvenation Res, 2013; 16:S13.
19.
CoeurnelleD. Collective consequences of a very long life. The right to life extension could/should be considered a human right. Rejuvenation Res, 2013; 16:S19.
20.
KhaltourinaD. Legal problems of registering substances and therapies to cure aging. Rejuvenation Res, 2013; 16:S27Collective consequences of a very long life. The right to life extension could/should be considered a human right. S28.
KuhnR. International futures: Impact of decelerated or abolished aging on human demographic change. Rejuvenation Res, 2013; 16:S29.
23.
PyszczynskiT, GreenbergJ. Understanding the paradox of opposition to long-term extension of the human lifespan: Fear of death, cultural worldviews, and the illusion of objectivity. Rejuvenation Res, 2013; 16:S36–S37.
24.
UnderwoodM, HallW, BartlettH. What reassurances do the community need regarding life extension? Evidence from studies of community attitudes and an analysis of film portrayals. Rejuvenation Res, 2013; 16:S42.
25.
LitovchenkoM, ZhavoronkovA. New economic arguments for accelerating aging research. Rejuvenation Res, 2013; 16:S44.
26.
MicansP. Why orthodox medicine must change—the need for preventative/regenerative medicine. Rejuvenation Res, 2013; 16:S45.
27.
de MagalhãesJP. The scientific quest for lasting youth: Prospects for curing aging. Rejuvenation Res, 2014; 17:458–467.
28.
KyriazisM. The impracticality of biomedical rejuvenation therapies: Translational and pharmacological barriers. Rejuvenation Res., 2014; 17:390–396.
29.
StamblerI. The unexpected outcomes of anti-aging, rejuvenation, and life extension studies: An origin of modern therapies. Rejuvenation Res, 2014; 17:297–305.
30.
GoldsmithTC. Aging theories and the zero-sum game. Rejuvenation Res, 2014; 17:1–2.
31.
NeedhamSL. Toward priorities for aging research. Rejuvenation Res, 2014; 17:154–156.
32.
ZimniakP. What is the proximal cause of aging?. Front Genet., 2012; 3:189.
33.
GlucksmannA. Cell deaths in normal vertebrate ontogeny. Biol Rev Camb Philos Soc, 1951; 26:59–86.
34.
JiangL. History of apoptosis research. Encyclopedia of Life Sciences, 06/2012; doi: 10.1002/9780470015902.a0023954.
